Merck & Co Inc (NYSE:MRK)

54.57
Delayed Data
As of 4:00pm ET
 +0.02 / +0.04%
Today’s Change
53.36
Today|||52-Week Range
66.80
-3.02%
Year-to-Date
52-Week Company Lows
10:37am / GuruFocus News - Paid Partner Content
U.K. blames Russia for crippling cyberattack
Feb 15 / CNNMoney.com
Merck to Buy Australian Firm to Boost Immunotherapy Pipeline
9:09am / Zacks.com - Paid Partner Content
Can ImmunoGen's Key Ovarian Cancer Candidate Drive Growth?
Feb 14 / Zacks.com - Paid Partner Content
9 Stocks Richard Pzena Continues to Buy
Feb 21 / GuruFocus News - Paid Partner Content
Merck (MRK) Halts Another Late Stage Study on Alzheimer's
Feb 14 / Zacks.com - Paid Partner Content
What's in Store for Agenus (AGEN) This Earnings Season?
Feb 21 / Zacks.com - Paid Partner Content
Pfizer Announces FDA Acceptance of NDA for NSCLC Candidate
Feb 13 / Zacks.com - Paid Partner Content
US Market Indexes Lower, Dow Jones Closes Below 25,000
Feb 20 / GuruFocus News - Paid Partner Content
ImmunoGen (IMGN) Q4 Loss Wider Than Expected, Revenues Grow
Feb 12 / Zacks.com - Paid Partner Content
US Stocks Lower Tuesday
Feb 20 / GuruFocus News - Paid Partner Content
The Zacks Analyst Blog Highlights: Merck, Goldman Sachs, Tesla, T-Mobile and Activisi...
Feb 12 / Zacks.com - Paid Partner Content
AstraZeneca's (AZN) Imfinzi Gets FDA Nod for Label Expansion
Feb 19 / Zacks.com - Paid Partner Content
Top Analyst Reports for Merck, Goldman Sachs & Tesla
Feb 09 / Zacks.com - Paid Partner Content
Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock (Revised)
Feb 16 / Zacks.com - Paid Partner Content
Solid Q4 Earnings Drive Pharma ETF Outlook
Feb 09 / Zacks.com - Paid Partner Content
FDA Sets the Stage for Earlier-Stage Alzheimer's Treatments
Feb 16 / Zacks.com - Paid Partner Content
U.S. jobs report; Exxon earnings; Casino panic
Feb 02 / CNNMoney.com
Incyte (INCY) Beats on Q4 Revenues on Strong Jakafi Sales
Feb 15 / Zacks.com - Paid Partner Content
Trump wants to fix 'injustice' of high drug prices. But can he?
Jan 31 / CNNMoney.com
Nektar, Bristol-Myers Tie-Up for Cancer Combos Drives Stock
Feb 15 / Zacks.com - Paid Partner Content
Turbulence returns to the stock market
Jan 31 / CNNMoney.com